Legislative staff talk about working during the pandemic and how they are connecting with constituents.... [Read More]
Vanessa Caceres is a freelance medical writer and editor based in Florida. She has a BA in journalism and psychology and a Master's degree in teaching English as a second language/bilingual education. She writes regularly for ophthalmology and rheumatology physician publications, as well as other specialties.
Articles by Vanessa Caceres
Advocacy 101 Teaches Legislative, Advocacy Basics
Bharat Kumar, MD, Advocacy 101 coordinator and Government Affairs Committee member, describes the virtual program designed to educate and empower rheumatology fellows in training, program directors and ARP members to advocate for issues that affect rheumatology practices and patients in advance of the Advocates for Arthritis that will take place virtually in September.... [Read More]
Ustekinumab for Behçet’s Disease? The Study Results Are In
In a multicenter, prospective, open-label study, ustekinumab therapy was effective in treating oral ulcers resistant to colchicine in patients with Behçet’s disease, according to study author David Saadoun, MD, PhD, Department of Internal Medicine and Clinical Immunology, Sorbonne University, Paris, and fellow researchers.1 Researchers focused on the topic because oral ulcers are often disabling, have… [Read More]
Minding the Money: A Conversation with Douglas White, MD, PhD, Finance Committee Chair
As chair, Dr. Douglas White hopes to find ways to diversify the ACR’s revenue streams and increase transparency around how the organization spends member dues.... [Read More]
Spotlight on Ethics & Conflicts of Interest: A Conversation with Karen Onel, MD, New Chair of the ACR’s Ethics Committee
Karen Onel, MD, new chair of ACR’s Committee on Ethics & Conflict of Interest, brings a longstanding interest in issues related to ethics and consent.... [Read More]
Making Rheumatologists’ Voices Count: A Conversation with Blair Solow, MD, Incoming Government Affairs Committee Chair
With multiple healthcare policy issues currently in play, Dr. Solow believes making rheumatologists’ voices heard is crucial to the specialty’s success.... [Read More]
New Study Asks Why Lupus Patients Don’t Take Their Hydroxychloroquine
Hydroxychloroquine (HCQ) therapy may effectively manage systemic lupus erythematosus (SLE) in many patients, but that doesn’t mean patients will take it as often as they should. In fact, results from a recently published study found that about half of SLE patients were not adherent.1 The study was led by Lucy H. Liu, MD, MPH, a… [Read More]
New Options for Patients with Concurrent Dry Eye & Rheumatic Disease
Dry eye affects at least 30 million people in the U.S. and many more around the globe. Among patients with autoimmune disease—including Sjögren’s syndrome and rheumatoid arthritis—that number can climb even higher. Although dry eye may sound like just an annoyance, it can range from mildly irritating to debilitating, depending on the extent of the… [Read More]
Common Characteristics in RA Patients Who Don’t Respond to Biologics
At least 6% of patients who used biologic disease-modifying anti-rheumatic drugs (bDMARDs) suffered refractory disease, according to a recent study based on data from the British Society for Rheumatology Biologics Registry for Rheumatoid Arthritis.1 This observational study evaluated the extent of biologic refractory rheumatoid arthritis (RA). The study defined biologic refractory disease as occurring in… [Read More]
Recent Research Probes Smoking & the Risk for Autoimmune Disease
It’s no secret to any health professional, including rheumatologists, that smoking cigarettes or using other tobacco-based products is unhealthy. Yet how does smoking specifically affect rheumatic diseases, and what are some of the newest findings in this area? What role do e-cigarettes have in the smoking risk landscape? Those are the sorts of questions asked… [Read More]
- 1
- 2
- 3
- …
- 7
- Next Page »